Trial intelligence / Profile preview

Stannous fluoride toothpaste for gingivitis control

NCT05916521Phase 4Completed

Sponsor
Procter & Gamble
Start
Nov 2021
Primary completion
Feb 2022
Modality
DNA Intercalators/Alkylators
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of stannous fluoride in gingivitis (3 arms), sponsored by Procter & Gamble. Primary endpoint: Löe-Silness Gingivitis Evaluation at Week 12. Started Nov 2021; status: completed.

02

Drugs

stannous fluoride
03

Conditions

gingivitis

Beyond the preview

Go deeper on NCT05916521.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05916521.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call